Aratana Therapeutics Inc. (PETX)

5.25 0 (0%)

IEX Real-Time Price

August 16, 2018 EST.

NASDAQ Global Market : Healthcare

Prev Close 5.25

Price Open 5

Volume: 424,734

Avg Volume: 264,096

Market Cap: 250.27M

P/E Ratio -7.19

52 Wk Range 3.67-7.28



PETX Short Interest Statistics


Report Date
Float Share
Short Interest
Short Ratio
Short % to Float

2018-07-31
45.84M
1.97M
10.48
4.30%

2018-07-13
45.33M
1.93M
5.49
4.27%

2018-06-29
45.33M
2.03M
5.44
4.47%

2018-06-15
45.33M
1.89M
6.99
4.18%




PETX Earning Report


Report Date
Fiscal Period
Announce Time
Estimated EPS(#)
Actual EPS
Surprise Dollar

2018-05-14
Q1 2018
N/A
-0.17 (4)
0.00
0.00

2018-05-04
Q1 2018
BTO
-0.17 (4)
0.00
0.00

2018-05-03
Q1 2018
AMC
-0.18 (4)
-0.19
-0.01

2018-03-14
Q4 2017
BTO
-0.23 (4)
-0.19
0.04

News

The latest portfolio moves by Engaged Capital (2018-08-14 15:26 SeekingAlpha)

Engaged Capital updates on its portfolio holdings as of the end of Q2. More news on: Universal Electronics Inc., Casey's General Stores, Inc., Groupon, Inc., Consumer stocks news, Tech stocks news, Read more …

 


Statistics

Shares Outstanding: 47.67M

Top 15 Institution Percent: 70.30

Price To Sales: 9.28

Price To Book: 2.54

Revenue: 6.16M

Gross Profit: 2.03M

Cash: 70.34M

Debt: 36.85M

Return On Assets: -28.10

Return On Equity: -40.75

Profit Margin: N/A

Price History

Beta: 2.77

50-day Moving Avg: 4.67

200-day Moving Avg: 5.01

YTD Change: -1.50

5-day Change: 2.24

1-month Change: 16.93

3-month Change: -5.23

6-month Change: 25.60

1-year Change: -4.89

Revenue Per Share: 0.00

Revenue Per Employee: 70034.00



Dividend

Dividend Yield: -

EX-Dividend Date: -

Dividend Rate: -


Company Profile

Name: Aratana Therapeutics Inc.

Exchange: NASDAQ Global Market

Industry: Biotechnology

Sector: Healthcare

Website: http://www.aratana.com

Aratana Therapeutics Inc is a pet therapeutics company. Its main activity is the licensing, developing, and commercializing of innovative biopharmaceutical products for companion animals.